Suchergebnisse - "Tang, Zihui"

PubPharm (61)

1

Model-based reasoning methods for diagnosis in integrative medicine based on electronic medical records and natural language processing

enthalten in: bioRxiv.org | 2024

von Geng, W. | Qin, X. | Wang, Z. | +3

2

S-nitrosylation of EMMPRIN influences the migration of HSCs and MMP activity in liver fibrosis

enthalten in: Acta biochimica et biophysica Sinica | 2023

von Zhu, X. | Tang, Z. | Li, W. | +3

3

Y-box binding protein 1 promotes chromatin accessibility to aggravate liver fibrosis

enthalten in: Cellular signalling | 2023

von Tang, Z. | Lin, B. | Li, W. | +3

4

Mesoporous polydopamine based biominetic nanodrug ameliorates liver fibrosis via antioxidation and TGF-β/SMADS pathway

enthalten in: International journal of biological macromolecules | 2023

von Tang, Z. | Li, X. | Tian, L. | +3

5

Risk prediction model based on blood biomarkers for predicting moderate to severe endoscopic activity in patients with ulcerative colitis

enthalten in: Frontiers in medicine | 2023

von Li, X. | Tang, Z. | Liu, Y. | +2

6

Dynamic Reach Deficit Is a Predictive Factor of Inferior Outcomes After Modified Broström Procedure for Lateral Ankle Instability

enthalten in: Foot & ankle international | 2022

von Cao, S. | Tang, Z. | Wang, C. | +5

7

Efficient electrocatalytic reduction of nitrate to nitrogen gas by a cubic Cu2O film with predominant (111) orientation

enthalten in: Chemical communications (Cambridge, England) | 2022

von Zhao, Q. | Tang, Z. | Chen, B. | +3

8

Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD : study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial

enthalten in: Trials | 2022

von Kong, Q. | Cao, Y. | Gao, Z. | +8

9

Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial

enthalten in: Trials | 2022

von Kong, Q. | Cao, Y. | Gao, Z. | +8

10

Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial

enthalten in: Trials | 2022

von Kong, Q. | Cao, Y. | Gao, Z. | +8

1
2
3
4
5
6
7
Nächster »
[7]